UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development

The Journal of pharmacology and experimental therapeutics, 2009-02, Vol.328 (2), p.364-370

2009

Volltextzugriff (PDF)

The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats

Biochemical pharmacology, 2012-04, Vol.83 (7), p.941-951

2012

Volltextzugriff (PDF)

Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders

Journal of Alzheimer's disease, 2008-12, Vol.15 (4), p.709-720

2008

Volltextzugriff (PDF)

Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing

The Journal of pharmacology and experimental therapeutics, 2007-09, Vol.322 (3), p.1117-1128

2007

Volltextzugriff (PDF)

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

Trends in pharmacological sciences (Regular ed.), 2005, Vol.26 (1), p.27-35

2005

Volltextzugriff (PDF)

A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

Biochemical pharmacology, 2009-10, Vol.78 (7), p.852-862

2009

Volltextzugriff (PDF)

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

British journal of pharmacology, 2006-07, Vol.148 (5), p.565-578

2006

Volltextzugriff (PDF)

Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets

Behavioural brain research, 2008-12, Vol.195 (1), p.30-38

2008

Volltextzugriff (PDF)

Guidelines on nicotine dose selection for in vivo research

Psychopharmacology, 2007-02, Vol.190 (3), p.269-319

2007

Volltextzugriff (PDF)

Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys

Psychopharmacologia, 2005-06, Vol.179 (4), p.725-732

2005

Volltextzugriff (PDF)

Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine

Neuroscience letters, 2007-02, Vol.413 (1), p.68-71

2007

Volltextzugriff (PDF)

Guidelines on nicotine dose selection for in vivo research

Psychopharmacologia, 2007-02, Vol.190 (3), p.269-319

2007

Volltextzugriff (PDF)

The potential role of cotinine in the cognitive and neuroprotective actions of nicotine

Life Sciences, 2003-05, Vol.72 (26), p.2931-2942

2003

Volltextzugriff (PDF)

Multifunctional Receptor-Directed Drugs for Disorders of the Central Nervous System

Neurotherapeutics, 2009, Vol.6 (1), p.4-13

Buccafusco, Jerry J.

2009

Volltextzugriff (PDF)

Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS

Molecular interventions, 2004-10, Vol.4 (5), p.285-295

Buccafusco, Jerry J

2004

Volltextzugriff (PDF)

Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain

ASN neuro, 2010-10, Vol.2 (4), p.e00044-e00044

2010

Volltextzugriff (PDF)

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

Trends in pharmacological sciences (Regular ed.), 2005-07, Vol.26 (7), p.352-360

2005

Volltextzugriff (PDF)

Anomaly in aortic arch alters pathological outcome of transient global ischemia in Rhesus macaques

Brain research, 2009-08, Vol.1286, p.185-191

2009

Volltextzugriff (PDF)

Cholinergic modulation of working memory activity in primate prefrontal cortex

Journal of neurophysiology, 2011-11, Vol.106 (5), p.2180-2188

2011

Volltextzugriff (PDF)

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures

The international journal of neuropsychopharmacology, 2010-09, Vol.13 (8), p.1035-1051

2010

Volltextzugriff (PDF)

Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: A pilot study

Brain research bulletin, 2007-09, Vol.74 (1), p.164-171

2007

Volltextzugriff (PDF)

The importance of brainstem cholinergic neurons in the pressor response to cocaine

The Journal of pharmacology and experimental therapeutics, 2005-01, Vol.312 (1), p.179-191

2005

Volltextzugriff (PDF)

Emerging cognitive enhancing drugs

Expert opinion on emerging drugs, 2009-12, Vol.14 (4), p.577-589

Buccafusco, Jerry J

2009

Volltextzugriff (PDF)

The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys

British journal of pharmacology, 2011-10, Vol.164 (3), p.970-978

2011

Volltextzugriff (PDF)

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Neurobiology of aging, 2004-09, Vol.25 (8), p.1023-1032

2004

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(161)

Publikationsform

Artikel
(185)

Sprache

Englisch
(185)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Animals
(136)
Science & Technology
(127)
Life Sciences & Biomedicine
(126)
Male
(97)
Rats
(85)
Neurosciences & Neurology
(81)
Neurosciences
(80)
Biological And Medical Sciences
(75)
Pharmacology & Pharmacy
(62)
Medical Sciences
(52)
Dose-Response Relationship, Drug
(43)
Humans
(36)
Rats, Wistar
(35)
Female
(31)
Macaca Mulatta
(29)
Pharmacology. Drug Treatments
(29)
Fundamental And Applied Biological Sciences. Psychology
(28)
Blood Pressure
(25)
Memory
(22)
Psychomotor Performance - Drug Effects
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development

The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats

Estimation of working memory in macaques for studying drugs for the treatment of cognitive disorders

Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets

Guidelines on nicotine dose selection for in vivo research

Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys

Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine

Guidelines on nicotine dose selection for in vivo research

The potential role of cotinine in the cognitive and neuroprotective actions of nicotine

Multifunctional Receptor-Directed Drugs for Disorders of the Central Nervous System

Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS

Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance

Anomaly in aortic arch alters pathological outcome of transient global ischemia in Rhesus macaques

Cholinergic modulation of working memory activity in primate prefrontal cortex

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures

Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: A pilot study

The importance of brainstem cholinergic neurons in the pressor response to cocaine

Emerging cognitive enhancing drugs

The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Suchergebnisse filtern